FISH studies identify the i(20q-) anomaly as a der(20)del(20)(q11q13) idic(20)(p11)

Genes Chromosomes and Cancer

Volumn 45, Issue 6, 2006, Pages 536-539

  Li, Tianyu ^a   Xue, Yongquan ^a   Wu, Yafang ^a   Pan, Jinlan ^a  

^a THE FIRST AFFILIATED HOSPITAL OF SOOCHOW UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CENTROMERE; CHROMOSOME 20P; CHROMOSOME ABERRATION; CHROMOSOME ANALYSIS; CHROMOSOME BREAKAGE; CHROMOSOME DELETION; CHROMOSOME G BAND; CHROMOSOME INVERSION; CHROMOSOME MAP; CHROMOSOME PAINTING; CHROMOSOME R BAND; CHROMOSOME REARRANGEMENT; CLINICAL ARTICLE; DICENTRIC CHROMOSOME; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; HUMAN TISSUE; MOLECULAR CLONING; MYELODYSPLASTIC SYNDROME; PRIORITY JOURNAL;

BONE MARROW CELLS; CHROMOSOME ABERRATIONS; CHROMOSOME BANDING; CHROMOSOME BREAKAGE; CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 20; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; KARYOTYPING; LEUKEMIA, MYELOCYTIC, ACUTE; MYELODYSPLASTIC SYNDROMES;

EID: 33646587402     PISSN: 10452257     EISSN: 10982264     Source Type: Journal    
DOI: 10.1002/gcc.20313     Document Type: Article

References (10)

1. Asimakopoulous FA, Green AR. 1996. Deletions of chromosome 20q and the pathogenesis of myeloproliferative disorders. Br J Haematol 95:219-226.
2. Cuneo A, Mecucci C, Hagemeijer A. 1999. Cytogenetic and molecular abnormalities in myeloid malignancies. In: Degos L, Linch DC, Lowenberg B, editors. Textbook of malignant haematology. London: Martin Dunity Ltd. p 205-207.
3. Dewald GW, Ketterling RP, Wyatt WA, Stupca PJ. 2003. Cytogenetic studies in neoplastic hematologic disorders. In: McClatchey KD, editor. Clinical Laboratory Medicine. Downers Grove, IL: Lippincott Williams & Wilkins. p 1-6.
4. Greenberg R Cox C, LeBeau MM, Fenaux P, Morel R Sanz G, Sanz M, Vallespi T, Hamblin T, Oscier D, Ohyashiki K, Toyama K, Aul C, Mufti G, Bennett J. 1997. International scoring system for evaluating prognosis in myelodysplastic syndromes. Blood 89:2079-2088.
5. Hunger SP. 1999. Cytogenetic and molecular abnormalities in lymphoid malignancies. In: Degos L, Linch DC, Lowenberg B, editors. Textbook of malignant haematology. London: Martin Dunity Ltd. p 188-189.
6. ISCN. 1995. An international system for human cytogenetic nomenclature. Mitelman F (ed). Basel, Switzerland: S. Karger.
7. Le Beau MM. 2001. Cytogenetics and gene rearrangement. In: Beutler E, Coller BS, Liehtman MA, Kipps JJ, Seligsohn U, editors. Williams Hematology. New York: McGraw-Hill. p 115.
8. Li T, Xue Y, Wu Y, Pan P. 2004. Clinical and molecular cytogenetic studies in seven patients with myeloid diseases characterized by i(20q-). Br J Haematol 125:337-342.
9. Saunders K, Czepulkowski B, Sivalingam R, Hayes JPLA, Aldouri M, Sekhar M, Cummins M, Ho A, Mufti GJ. 2005. Isochromosome of a deleted 20q: a rare but recurrent chromosome abnormality in myelodysplastic syndromes. Cancer Genet Cytogenet 156:154-157.
10. Wattel E, Lai JL, Hebbar M, Preudhomme C, Grahek D, Morel P, Bauters F, Fenaux P. 1993. De nove myelodysplastic syndrome (MDS) with deletion of the long arm of chromosome 20: a subtype of MDS with distinct hematological and prognostic features? Leuk Res 17:921-926.